Our data further support the notion that an effective mounting of an antitumor response is multifactorial and does not only rely on successful reinvigoration of exhausted T cells, but also on tumor burden and preexisting TCR clonality in addition to previously described predictive biomarkers like PD-L1 expression, TMB, and T-cell infiltration. The gene discussed is CD274; the disease is neoplasm.